These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?]. Klose G MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683 [No Abstract] [Full Text] [Related]
24. Cost-effectiveness of high-dose atorvastatin compared with usual-dose simvastatin: less than IDEAL? Kaul P Eur Heart J; 2007 Jun; 28(12):1405-6. PubMed ID: 17553925 [No Abstract] [Full Text] [Related]
25. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too]. MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641 [No Abstract] [Full Text] [Related]
26. High-dose statins for diabetes. Health News; 2006 Aug; 12(8):11. PubMed ID: 16917968 [No Abstract] [Full Text] [Related]
27. Risk factors for rhabdomyolysis with simvastatin and atorvastatin. Golomb B; Evans M Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465 [No Abstract] [Full Text] [Related]
28. Statins in acute coronary syndromes: the sooner, the better? Schwartz GG Am Heart J; 2005 Mar; 149(3):377-80. PubMed ID: 15864223 [No Abstract] [Full Text] [Related]
30. [CARDS confirms usefulness of LDL lowering in type 2 diabetics]. Bern VH Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1830. PubMed ID: 15559908 [No Abstract] [Full Text] [Related]
31. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. Gotto AM N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309745 [No Abstract] [Full Text] [Related]
32. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin. Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005 [TBL] [Abstract][Full Text] [Related]
33. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study. Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326 [TBL] [Abstract][Full Text] [Related]
34. High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease. Stoekenbroek RM; Boekholdt SM; Fayyad R; Laskey R; Tikkanen MJ; Pedersen TR; Hovingh GK; Heart; 2015 Mar; 101(5):356-62. PubMed ID: 25595417 [TBL] [Abstract][Full Text] [Related]
35. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. Paradis JM; LeLorier J N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309744 [No Abstract] [Full Text] [Related]
36. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease. Clearfield M Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005 [No Abstract] [Full Text] [Related]
37. Statin therapy after stroke or transient ischemic attack. East JE N Engl J Med; 2006 Nov; 355(22):2368-9; author reply 2370-1. PubMed ID: 17139775 [No Abstract] [Full Text] [Related]
38. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. Miller M N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309746 [No Abstract] [Full Text] [Related]
39. Use of high-intensity statin therapy with simvastatin 80 mg and atorvastatin 80 mg in primary care. Meek CL; Reston JD; Ramsbottom T; Pathmanathan H; Viljoen A Int J Clin Pract; 2011 Feb; 65(2):120-6. PubMed ID: 21235694 [TBL] [Abstract][Full Text] [Related]
40. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Zhou Z; Rahme E; Pilote L Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]